Meet attyloid at BIO-Europe 2026
We are pleased to announce that attyloid will be exhibiting at BIO-Europe 2026 in Cologne, November 9–11, as part of the North Rhine-Westphalia (NRW) Joint Pavilion.
At the event, we will showcase how our complementary biomarker technologies provide deeper insights into neurodegenerative disease biology and support CNS drug development:
- sFIDA®: Highly sensitive quantification and sizing of pathological protein oligomers, enabling the assessment of target engagement and treatment response.
- NULISA™: Ultra-sensitive profiling of hundreds of CNS-relevant protein biomarkers, powered by our partner Alamar Biosciences, Inc.
Together, these technologies provide complementary insights into disease pathology, pharmacodynamic effects, and treatment responses, helping researchers make more informed decisions throughout CNS drug development.
We invite you to visit us at the NRW Joint Pavilion or connect with us through the BIO-Europe Partnering Portal to arrange a meeting.
We look forward to seeing you in Cologne!
November 9–11, 2026 | Cologne, Germany